CD44: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load=' | <StructureSection load='4pz3' size='350' side='right' scene='' caption='Human CD44 hyaluronan-binding domain complex with tetrapeptide (PDB code [[4pz3]])'> | ||
| Line 11: | Line 11: | ||
CD44 is a potential drug target for treatment of malignant neoplasms. Anti-CD44 antibody treatment lowers hyperglycemia and chronic inflammatory diseases. | CD44 is a potential drug target for treatment of malignant neoplasms. Anti-CD44 antibody treatment lowers hyperglycemia and chronic inflammatory diseases. | ||
</StructureSection> | </StructureSection> | ||
==3D structures of CD44== | ==3D structures of CD44== | ||
